Ban T A, Guy W, Wilson W H, Kelwala S
Int Pharmacopsychiatry. 1982;17(3):153-62. doi: 10.1159/000468571.
There is evidence to indicate that 15% of patients diagnosed as schizophrenic will become chronically hospitalized, and that worldwide one-third to one-half of all psychiatric beds are occupied by schizophrenic patients. In spite of these figures and the public health problem they represent, little attention is paid to chronic hospitalized schizophrenic patients. Even the most recent classification schemas fail to recognize the heterogeneity, exemplified by differential responsiveness to psychotropic drugs, within the chronic schizophrenic population. One systematic approach to classification which does address this problem has been proposed by Leonhard. In this paper, findings and procedures that demonstrate the clinical relevance of Leonhard's system along with some preliminary results and observations from psychopharmacological studies that indicate Leonhard's different subtypes of chronic schizophrenia may represent biologically distinct populations are presented.
有证据表明,被诊断为精神分裂症的患者中有15%会长期住院,且在全球范围内,所有精神病床位的三分之一到二分之一被精神分裂症患者占据。尽管有这些数据以及它们所代表的公共卫生问题,但慢性住院的精神分裂症患者却很少受到关注。即使是最新的分类方案也未能认识到慢性精神分裂症患者群体内部的异质性,这种异质性表现为对精神药物的反应不同。莱昂哈德提出了一种解决这一问题的系统性分类方法。本文介绍了一些研究结果和程序,这些结果和程序证明了莱昂哈德系统的临床相关性,同时还介绍了一些精神药理学研究的初步结果和观察结果,这些结果表明莱昂哈德所划分的慢性精神分裂症不同亚型可能代表生物学上不同的群体。